Octapharma presents research on congenital & acquired bleeding disorders at ASH Meeting ...Middle East

Octapharma USA will present multiple clinical research posters focused on the efficacy and safety of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for Intravenous Use in the treatment of congenital and acquired bleeding disorders during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, a virtual medical congress to be held December 5 - 8, 2020.

Read More Details
Finally We wish PressBee provided you with enough information of ( Octapharma presents research on congenital & acquired bleeding disorders at ASH Meeting )

Also on site :

• Numbrix 9 - May 11
• PM affirms key role of NERIC factory in railway industry localization
• Huge restaurant fire in Heliopolis kills 1 person, injures 3 more